Literature DB >> 11169048

Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila.

J H Helbig1, P C Lück, M Steinert, E Jacobs, M Witt.   

Abstract

The macrophage infectivity potentiator (Mip) protein is an important factor in the optimal intracellular survival of Legionella pneumophila in protozoa and human cell lines. In this study we have localized the Mip protein in Legionella grown on buffered charcoal yeast extract (BCYE) agar as well as in Legionella which were ingested by Acanthamoeba castellanii. Immunogold techniques have shown that Mip is exposed on the cell surface of extracellularly grown bacteria. In A. castellanii infected with Legionella the Mip protein was also detected on host membranes which exhibited a multilamellar structure. The morphology of these structures is similar to that of respirable vesicles of amoebas by which live legionellas may be transmitted to humans. It can be assumed that the accumulation of Mip protein in the multilamellar host membranes increases the infection potential.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169048     DOI: 10.1046/j.1472-765x.2001.00861.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  10 in total

Review 1.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.

Authors:  Miao-Chiu Hung; Omar Salim; Jeannette N Williams; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

3.  Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.

Authors:  Magdalena K Bielecka; Nathalie Devos; Mélanie Gilbert; Miao-Chiu Hung; Vincent Weynants; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

4.  Legionella pneumophila Mip, a surface-exposed peptidylproline cis-trans-isomerase, promotes the presence of phospholipase C-like activity in culture supernatants.

Authors:  Sruti Debroy; Virginia Aragon; Sherry Kurtz; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

5.  1H, 13C, 15N backbone and sidechain resonance assignment of Mip(77-213) the PPIase domain of the Legionella pneumophila Mip protein.

Authors:  Martin Horstmann; Thilo Kamphausen; Kristian Schweimer; Michael Steinert; Jörg Hacker; Axel Haase; Paul Rösch; Gunter Schweimer; Cornelius Faber
Journal:  J Biomol NMR       Date:  2005-01       Impact factor: 2.835

6.  Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila.

Authors:  Rolf Köhler; Jörg Fanghänel; Bettina König; Edeltraud Lüneberg; Matthias Frosch; Jens-Ulrich Rahfeld; Rolf Hilgenfeld; Gunter Fischer; Jörg Hacker; Michael Steinert
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

7.  GldI is a lipoprotein that is required for Flavobacterium johnsoniae gliding motility and chitin utilization.

Authors:  Mark J McBride; Timothy F Braun
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

8.  Surface display of a massively variable lipoprotein by a Legionella diversity-generating retroelement.

Authors:  Diego Arambula; Wenge Wong; Bob A Medhekar; Huatao Guo; Mari Gingery; Elizabeth Czornyj; Minghsun Liu; Sanghamitra Dey; Partho Ghosh; Jeff F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-30       Impact factor: 11.205

9.  Solution structure of the Legionella pneumophila Mip-rapamycin complex.

Authors:  Andreas Ceymann; Martin Horstmann; Philipp Ehses; Kristian Schweimer; Anne-Katrin Paschke; Michael Steinert; Cornelius Faber
Journal:  BMC Struct Biol       Date:  2008-03-17

10.  Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila.

Authors:  Janine Rasch; Martin Theuerkorn; Can Ünal; Natascha Heinsohn; Stefan Tran; Gunter Fischer; Matthias Weiwad; Michael Steinert
Journal:  Front Bioeng Biotechnol       Date:  2015-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.